Tadocizumab (C4G1, YM-337) is a humanized monoclonal antibody tageting integrin alphaIIbbeta3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research[1][2].
Purity:
97
CAS Number:
[339086-80-5]
Target:
Integrin
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted